- Home
- PRQR vs SKIN Comparison
PRQR vs SKIN Comparison
Compare PRQR & SKIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PRQR | SKIN |
|---|---|---|
| Founded | 2012 | 1997 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 173.8M | 179.8M |
| IPO Year | 2014 | N/A |
Fundamental Metrics
Financial Performance| Metric | PRQR | SKIN |
|---|---|---|
| Price | $1.69 | $1.53 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | ★ $8.14 | $2.00 |
| AVG Volume (30 Days) | ★ 537.7K | 358.0K |
| Earning Date | 03-12-2026 | 03-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $18,859,556.00 | ★ $301,917,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $18.44 | $4.41 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $1.07 | $0.78 |
| 52 Week High | $3.10 | $2.69 |
Technical Indicators
Market Signals| Indicator | PRQR | SKIN |
|---|---|---|
| Relative Strength Index (RSI) | 37.79 | 53.61 |
| Support Level | $1.58 | $1.50 |
| Resistance Level | $1.80 | $1.58 |
| Average True Range (ATR) | 0.14 | 0.08 |
| MACD | 0.00 | 0.00 |
| Stochastic Oscillator | 13.67 | 51.04 |
Price Performance
Historical ComparisonAbout PRQR ProQR Therapeutics N.V.
ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.
About SKIN The Beauty Health Company
The Beauty Health Co is a category-creating beauty health company that along with its subsidiaries designs, develops, manufactures, markets and sells esthetic technologies and products. The company's brand portfolio includes Hydrafacial, SkinStylus, and Keravive, offering Syndeo device, SkinStylus SteriLock Microsystem, Keravive Peptide Solution and other products.